Drug Trial Radar · NCT03466073
A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
Last checked: Nov 20, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
Aug 28, 2018
Primary completion
Apr 2, 2019
Study completion Apr 2, 2019
Sponsor
- Lead sponsor
- BioAegis Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 15, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b/2a, Double-blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Plasma gelsolin (rhu-pGSN) Added to Standard of Care in Subjects Hospitalized for Acute Community-acquired Pneumonia (CAP)
Conditions
- Community-acquired Pneumonia
Interventions
Recombinant Human Plasma GelsolinDrug
Recombinant human plasma gelsolin lyophilized for reconstitution, reconstituted in sterile water
Normal Saline PlaceboOther
Normal saline in volume equivalent to drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: 0-28 days
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Cairns Hospital
Cairns, Queensland, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
Footscray Hospital
Footscray, Victoria, Australia
LTD Geo Hospitals, Mtskheta Multiprofile Medical Center
Mtskheta, Georgia
JSC Rustavi Central Hospital
Rustavi, Georgia
LTD Central University Clinic After Academic N. Kipshidze
Tbilisi, Georgia
LTD S. Khechinashvili University Hospital
Tbilisi, Georgia
LTD 5th Clinical Hospital
Tbilisi, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.